Cyclacel Pharmaceuticals
CYCC
CYCC
33 hedge funds and large institutions have $29.2M invested in Cyclacel Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
33
Holders Change
+16
Holders Change %
+94.12%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SFM
1
Sphera Funds Management
Tel Aviv,
Israel
|
$3.61M |
2 |
JGC
2
J. Goldman & Co
New York
|
$2.54M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$2.09M |
4 |
TLP
4
Tri Locum Partners
New York
|
$2.09M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.13M |